Abstract
The intestine is responsible for nutrient absorption and orchestrates metabolism in different organs during feeding, a process which is partly controlled by intestine-derived hormones. However, it is unclear whether the intestine plays an important role in metabolism during fasting. Here we have identified a novel hormone, famsin, which is secreted from the intestine and promotes metabolic adaptations to fasting. Mechanistically, famsin is shed from a single-pass transmembrane protein, Gm11437, during fasting and then binds OLFR796, an olfactory receptor, to activate intracellular calcium mobilization. This famsin-OLFR796 signaling axis promotes gluconeogenesis and ketogenesis for energy mobilization, and torpor for energy conservation during fasting. In addition, neutralization of famsin by an antibody improves blood glucose profiles in diabetic models, which identifies famsin as a potential therapeutic target for treating diabetes. Therefore, our results demonstrate that communication between the intestine and other organs by a famsin-OLFR796 signaling axis is critical for metabolic adaptations to fasting.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout







References
Cahill, G. F. Jr Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1–22 (2006).
Jensen, T. L., Kiersgaard, M. K., Sorensen, D. B. & Mikkelsen, L. F. Fasting of mice: a review. Lab. Anim. 47, 225–240 (2013).
Geiser, F. Metabolic rate and body temperature reduction during hibernation and daily torpor. Annu. Rev. Physiol. 66, 239–274 (2004).
Gluck, E. F., Stephens, N. & Swoap, S. J. Peripheral ghrelin deepens torpor bouts in mice through the arcuate nucleus neuropeptide Y signaling pathway. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1303–R1309 (2006).
Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999).
Swoap, S. J. The pharmacology and molecular mechanisms underlying temperature regulation and torpor. Biochem. Pharmacol. 76, 817–824 (2008).
Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415–425 (2007).
Mani, B. K. & Zigman, J. M. Ghrelin as a survival hormone. Trends Endocrinol. Metab. 28, 843–854 (2017).
Potthoff, M. J., Kliewer, S. A. & Mangelsdorf, D. J. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev. 26, 312–324 (2012).
Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55–71 (2021).
Holst, J. J., Gribble, F., Horowitz, M. & Rayner, C. K. Roles of the gut in glucose homeostasis. Diabetes Care 39, 884–892 (2016).
Priest, C. & Tontonoz, P. Inter-organ cross-talk in metabolic syndrome. Nat. Metab. 1, 1177–1188 (2019).
Small, C. J. & Bloom, S. R. Gut hormones and the control of appetite. Trends Endocrinol. Metab. 15, 259–263 (2004).
Drucker, D. J. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 27, 740–756 (2018).
Müller, T. D. et al. Glucagon-like peptide 1 (GLP-1). Mol. Metab. 30, 72–130 (2019).
Bugge, K., Lindorff-Larsen, K. & Kragelund, B. B. Understanding single-pass transmembrane receptor signaling from a structural viewpoint-what are we missing? FEBS J. 283, 4424–4451 (2016).
Pahl, M. C et al. Signalling via single-pass transmembrane proteins. In eLS (John Wiley & Sons Ltd: Chichester, UK, 2013).
Lichtenthaler S. F., Lemberg M. K., Fluhrer R. Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments. EMBO J. 37, e99456 (2018).
Petersen, M. C., Vatner, D. F. & Shulman, G. I. Regulation of hepatic glucose metabolism in health and disease. Nat. Rev. Endocrinol. 13, 572–587 (2017).
Altarejos, J. Y. & Montminy, M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 12, 141–151 (2011).
Lin, H. V. & Accili, D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 14, 9–19 (2011).
Seidah, N. G. & Prat, A. The biology and therapeutic targeting of the proprotein convertases. Nat. Rev. Drug Discov. 11, 367–383 (2012).
Challet, E. The circadian regulation of food intake. Nat. Rev. Endocrinol. 15, 393–405 (2019).
Zhang, J., Kaasik, K., Blackburn, M. R. & Lee, C. C. Constant darkness is a circadian metabolic signal in mammals. Nature 439, 340–343 (2006).
Gavrilova, O. et al. Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 96, 14623–14628 (1999).
Buck, L. & Axel, R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 65, 175–187 (1991).
Pilpel, Y. & Lancet, D. The variable and conserved interfaces of modeled olfactory receptor proteins. Protein Sci. 8, 969–977 (1999).
Wang, Y. et al. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Nature 485, 128–132 (2012).
Ozcan, L. et al. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab. 15, 739–751 (2012).
Perry, R. J. et al. Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis. Nature 579, 279–283 (2020).
Jones, D. T. & Reed, R. R. Golf: an olfactory neuron specific-G protein involved in odorant signal transduction. Science 244, 790–795 (1989).
Belluscio, L., Gold, G. H., Nemes, A. & Axel, R. Mice deficient in G(olf) are anosmic. Neuron 20, 69–81 (1998).
Zhang, Z. et al. Estrogen-sensitive medial preoptic area neurons coordinate torpor in mice. Nat. Commun. 11, 6378 (2020).
Hrvatin, S. et al. Neurons that regulate mouse torpor. Nature 583, 115–121 (2020).
Takahashi, T. M. et al. A discrete neuronal circuit induces a hibernation-like state in rodents. Nature 583, 109–114 (2020).
Heller, H. C. & Ruby, N. F. Sleep and circadian rhythms in mammalian torpor. Annu. Rev. Physiol. 66, 275–289 (2004).
Ruby, N. F. & Zucker, I. Daily torpor in the absence of the suprachiasmatic nucleus in Siberian hamsters. Am. J. Physiol. 263, R353–R362 (1992).
van der Vinne, V., Bingaman, M. J., Weaver, D. R. & Swoap, S. J. Clocks and meals keep mice from being cool. J. Exp. Biol. 221, jeb179812 (2018).
Bellono, N. W. et al. Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170, 185–198.e16 (2017).
Chang, A. J., Ortega, F. E., Riegler, J., Madison, D. V. & Krasnow, M. A. Oxygen regulation of breathing through an olfactory receptor activated by lactate. Nature 527, 240–244 (2015).
Griffin, C. A., Kafadar, K. A. & Pavlath, G. K. MOR23 promotes muscle regeneration and regulates cell adhesion and migration. Dev. Cell 17, 649–661 (2009).
Shepard, B. D. et al. A renal olfactory receptor aids in kidney glucose handling. Sci. Rep. 6, 35215 (2016).
Li, E. et al. OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metab. 30, 319–328.e318 (2019).
Orecchioni, M. et al. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science 375, 214–221 (2022).
Cheng, J. et al. Autonomous sensing of the insulin peptide by an olfactory G protein-coupled receptor modulates glucose metabolism. Cell Metab. 34, 240–255.e210 (2022).
Wu, C. et al. Olfactory receptor 544 reduces adiposity by steering fuel preference toward fats. J. Clin. Invest. 127, 4118–4123 (2017).
Lee, S. J., Depoortere, I. & Hatt, H. Therapeutic potential of ectopic olfactory and taste receptors. Nat. Rev. Drug Discov. 18, 116–138 (2019).
Soty, M., Gautier-Stein, A., Rajas, F. & Mithieux, G. Gut-brain glucose signaling in energy homeostasis. Cell Metab. 25, 1231–1242 (2017).
Abizaid, A. & Hougland, J. L. Ghrelin signaling: GOAT and GHS-R1a take a LEAP in complexity. Trends Endocrinol. Metab. 31, 107–117 (2020).
Goldstein, J. L. et al. Surviving starvation: essential role of the ghrelin-growth hormone axis. Cold Spring Harb. Symp. Quant. Biol. 76, 121–127 (2011).
Sinclair, P., Brennan, D. J. & le Roux, C. W. Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer. Nat. Rev. Gastroenterol. Hepatol. 15, 606–624 (2018).
Dimitriadis, G. K., Randeva, M. S. & Miras, A. D. Potential hormone mechanisms of bariatric surgery. Curr. Obes. Rep. 6, 253–265 (2017).
Rubino, F., Schauer, P. R., Kaplan, L. M. & Cummings, D. E. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu. Rev. Med. 61, 393–411 (2010).
Fernandez, C. et al. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J. Intern. Med. 284, 377–387 (2018).
Odegaard, J. I. et al. Perinatal licensing of thermogenesis by IL-33 and ST2. Cell 166, 841–854 (2016).
Zhao, B. et al. The non-muscle-myosin-II heavy chain Myh9 mediates colitis-induced epithelium injury by restricting Lgr5+ stem cells. Nat. Commun. 6, 7166 (2015).
Haber, A. L. et al. A single-cell survey of the small intestinal epithelium. Nature 551, 333–339 (2017).
Han, J. et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature 524, 243–246 (2015).
Le Gall, S. M., Auger, R., Dreux, C. & Mauduit, P. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J. Biol. Chem. 278, 45255–45268 (2003).
Ge, L., Melville, D., Zhang, M. & Schekman, R. The ER-Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis. Elife 2, e00947 (2013).
Wang, Y. et al. Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc. Natl. Acad. Sci. USA 107, 3087–3092 (2010).
Acknowledgements
We thank Drs. Haiteng Deng, Zhongchen Xie, Ye-Guang Chen, Tong-Jin Zhao, Shengcai Lin, Liangyou Rui, Y. Eugene Chen, Cheng Zhan, Jay D. Horton, Wei Shen and all lab members for discussion and technical help. We thank Dr. Isabel Hanson for editing. This work was supported by grants from the National Natural Science Foundation of China (91957206 and 82088102), Tsinghua University Initiative Scientific Research Program (2021Z11JCQ016) and the Ministry of Science and Technology of the People’s Republic of China (2021YFA0804801).
Author information
Authors and Affiliations
Contributions
A.L., Y.L., X.F., L.J. and Z.L. performed the experiments. J.H., S.W., C.C. and P.H. collected the basic parameters from human blood samples. Y.W. conceived, designed and supervised this study, and wrote the manuscript. All authors reviewed and commented on the manuscript.
Corresponding authors
Ethics declarations
Competing interests
Y.W., A.L. and Y.L. have one pending patent application. All other authors declare no competing interests.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Long, A., Liu, Y., Fang, X. et al. Famsin, a novel gut-secreted hormone, contributes to metabolic adaptations to fasting via binding to its receptor OLFR796. Cell Res (2023). https://doi.org/10.1038/s41422-023-00782-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41422-023-00782-7